Temenos Multifonds étend son partenariat avec Citi Securities Services en vue de consolider les services de fonds globaux sur le SaaS Multifonds
May 09, 2024 07:02 ET
|
Temenos
GENÈVE, Suisse, 09 mai 2024 (GLOBE NEWSWIRE) -- Temenos (SIX : TEMN) a annoncé, ce jour, que Multifonds avait étendu sa relation avec Citi Securities Services en vue de consolider son opération...
Xometry Reports First Quarter 2024 Results
May 09, 2024 07:02 ET
|
Xometry, Inc.
Xometry Reports First Quarter 2024 Results
HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
May 09, 2024 07:01 ET
|
HOOKIPA Pharma Inc.
Phase 2/3 pivotal trial design and protocol for HB-200 in combination with pembrolizumab for the first-line treatment of patients with HPV16+ recurrent or metastatic OPSCC aligns with U.S. Food and...
Prelude Therapeutics to Participate in Citizens JMP Life Sciences Conference
May 09, 2024 07:01 ET
|
Prelude Therapeutics, Inc.
WILMINGTON, Del., May 09, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will...
Tower Semiconductor Reports 2024 First Quarter Financial Results
May 09, 2024 07:00 ET
|
Tower Semiconductor
MIGDAL HAEMEK, Israel, May 09, 2024 (GLOBE NEWSWIRE) -- Tower Semiconductor (NASDAQ: TSEM & TASE: TSEM) reports today its results for the first quarter ended March 31, 2024. First Quarter...
Advantage Solutions Reports First Quarter Results with New Reporting Segments and Reaffirms its 2024 Outlook
May 09, 2024 07:00 ET
|
Advantage Solutions, Inc.
Management reaffirms its 2024 outlook as first-quarter results met expectations despite soft market conditions and higher-than-expected costs and investments.Inclusive of discontinued operations,...
Royalty Pharma Reports First Quarter 2024 Results
May 09, 2024 07:00 ET
|
Royalty Pharma plc
Royalty Receipts growth of 14% driving Portfolio Receipts of $717 millionNet cash provided by operating activities of $665 millionFull year 2024 guidance confirmed: Portfolio Receipts expected to be...
ASLAN Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 09, 2024 07:00 ET
|
ASLAN PHARMACEUTICALS LIMITED
Positive interim data readout from 22 patients in TREK-DX study of eblasakimab showed unprecedented efficacy data compared to prior atopic dermatitis (AD) studies with biologics: 60.0% of...
GPT Invest App - Transforming Investment Search for Canadian Users with AI
May 09, 2024 07:00 ET
|
InvestGPT Review
Markham, Ontario, May 09, 2024 (GLOBE NEWSWIRE) -- Introducing GPT Invest App, the groundbreaking AI-powered investment search tool tailored specifically for Canadian users. This innovative app is...
Optinose Announces $55 Million Registered Direct Offering
May 09, 2024 07:00 ET
|
Optinose, Inc.
Led by Nantahala Capital and The D. E. Shaw Group with participation from existing and new investors Post-offering cash balance of ~$100 million expected to fund operating plan through 2025 ...